Skip to content
Cornea & External Eye

Subconjunctival Hemorrhage

Subconjunctival hemorrhage (SCH, hyposphagma) is a condition in which bleeding from conjunctival blood vessels accumulates in the subconjunctival space (between the bulbar conjunctiva and Tenon’s capsule). Causes include inflammation such as acute hemorrhagic conjunctivitis, external stressors like trauma or surgery, increased venous pressure due to coughing or vomiting, anticoagulant therapy such as warfarin, coagulation abnormalities, vascular abnormalities, and vascular fragility due to hypertension or diabetes. Because the bulbar conjunctiva is loosely attached to the subconjunctival tissue and sclera, even a small amount of bleeding is clearly visible to the naked eye.

Appearance and local cross-section of a subconjunctival hemorrhage. On the left, a broad area of the white of the eye is bright red, while the cornea is clear and the iris and pupil are visible. On the right, a magnified view of the selected hemorrhage site: 1 indicates the conjunctiva, 2 the blood beneath it, and 3 the deeper white sclera.
Original illustration by Lumic (CC BY 4.0)
Even if a subconjunctival hemorrhage looks dramatic, in most cases it does not affect vision and is absorbed naturally.
① Conjunctiva ② Blood beneath the conjunctiva ③ Sclera

Historically called “hyposphagma” (from Greek meaning “covered with blood”), case reports have accumulated in Western medicine since the 1800s. The standardized Japanese medical term corresponds to “subconjunctival hemorrhage,” while laypeople may refer to it as “bleeding in the white of the eye.” The condition occurs when blood vessels in the subconjunctival space — located between the superficial conjunctiva and Tenon’s capsule — rupture, often appearing as a well-demarcated, flat area of hemorrhage. In severe cases, it may elevate into a bullous hemorrhage, making eyelid closure difficult.

It accounts for approximately 3% of all ophthalmic outpatient visits and is found in 2.9% of patients whose chief complaint is hyperemia. Among individuals aged 65 years or older, the prevalence rises to 10.1%, being more common in older adults10). A large cross-sectional study by Mimura et al. involving 8,726 Japanese patients with hyperemia confirmed similar rates10), with no significant differences by age or sex reported. In a review by Tarlan et al., many cases were considered idiopathic due to difficulty in identifying the cause, with approximately half of the cases having an unknown cause in the cited studies12). Trauma, hypertension, diabetes, and anticoagulants are major associated factors; trauma and contact lenses are frequently associated in younger patients, whereas systemic vascular diseases are more common in older adults12). During epidemics of acute hemorrhagic conjunctivitis, this infection may become a primary cause.

Most cases resolve spontaneously within 1 to 4 weeks without sequelae. During absorption, the hemorrhage gradually changes color from red to purple, then blue-green, and finally yellow. There is no effect on vision. However, recurrent or persistent cases warrant investigation for systemic disease, neoplasms, or coagulation disorders.

Q Is subconjunctival hemorrhage a dangerous condition?
A

An isolated subconjunctival hemorrhage is benign and does not affect vision. It typically resolves spontaneously within 1 to 4 weeks. However, if it recurs or fails to resolve over a prolonged period, there may be an underlying serious systemic condition such as hypertension, diabetes, coagulation disorder, or tumor. There have been reports of Kaposi sarcoma discovered masquerading as subconjunctival hemorrhage1).

Three slit-lamp photographs of subconjunctival hemorrhage (bleeding and absorption process)
Lau AZ, Tang GY, Morgan WH, Chan GZ. Drainage of subconjunctival hemorrhage through conjunctival lymphatic pathways. American journal of ophthalmology case reports. 2025;39:102368. doi:10.1016/j.ajoc.2025.102368. PMID:40686767; PMCID:PMC12272577. Fig. 2. PMCID: PMC12272577. License: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/).
Three slit-lamp photographs show the course of subconjunctival hemorrhage on postoperative day 1 (A), day 2 (B), and at 2 weeks (C). White arrows indicate the hemorrhage site, and green arrows indicate blood-filled lymphatic structures. The sequence shows spontaneous absorption of the blood and associated color changes.
  • Mostly asymptomatic: Subconjunctival hemorrhage alone does not involve pain or vision loss.
  • Foreign body sensation: Some patients may complain of dry eye-related symptoms.
  • Awareness of redness: Patients often notice it when looking in the mirror, or are told by others and seek medical attention.

Clinical Findings (Findings Confirmed by Physician Examination)

Section titled “Clinical Findings (Findings Confirmed by Physician Examination)”
  • Hemorrhagic patch: A bright red or dark red hemorrhagic patch is seen under the bulbar conjunctiva. It ranges from localized punctate or blotchy spots to diffuse spread across the entire bulbar conjunctiva. It changes color to pink, orange, and yellow during the absorption process.
  • Location of bleeding: More common in the inferior conjunctiva than the superior conjunctiva. In trauma and diabetes, it is more common on the temporal side than the nasal side.
  • Bullous elevation: In severe cases, the conjunctiva swells in a bullous manner, making eyelid closure difficult. There are reports of 360-degree bullous subconjunctival hemorrhage occurring after intravitreal injection in a patient with severe hemophilia A, leading to inability to close the eyelid2).
  • Associated findings: Often accompanied by dry eye, punctate keratopathy, superior limbic keratoconjunctivitis, lid-wiper epitheliopathy, pinguecula, and conjunctivochalasis.
  • Danger signs: When accompanied by hyperemia, discharge, conjunctival laceration, hyphema, or iritis, further investigation of the underlying condition such as trauma, contusion, or infectious conjunctivitis is necessary. Conjunctival lacerations hidden by bleeding are easy to miss, so careful slit-lamp examination is required.
  • Differential diagnosis from acute hemorrhagic conjunctivitis: In acute hemorrhagic conjunctivitis (AHC) caused by enterovirus 70 (EV70) and coxsackievirus A24 variant (CA24v), subconjunctival hemorrhage appears in 70–90% of all AHC cases, presenting abruptly with bilateral involvement, follicular conjunctivitis, and preauricular lymphadenopathy9). The incubation period is extremely short at approximately one day, and even unilateral cases often become bilateral the following day. Hemorrhages range from patchy or petechial to extensive, taking on a spread-out appearance 3–5 days after onset. Repeated outbreaks have been reported in Japan, including the EV70 epidemic in Okinawa in 1994 and the CA24v epidemic in Okinawa in 20119). Epidemic history, contact history, and the presence or absence of bilateral involvement are important for diagnosis.

Bleeding occurs between Tenon’s capsule and the conjunctiva due to damage to conjunctival blood vessels. In older adults, the elastic and connective tissues between Tenon’s capsule and the conjunctiva are fragile, making bleeding more likely to spread.

Risk FactorMechanism
IdiopathicUnknown cause
TraumaDirect damage to conjunctival blood vessels
Systemic hypertensionMain cause in people aged 50 and over
Diabetes mellitusFragility due to microvascular damage8)
WarfarinSCH incidence 3.7% in users, 1.7% in non-users7)
DOAC (Direct Oral Anticoagulant)Apixaban, rivaroxaban, edoxaban, dabigatran, etc. Self-discontinuation is common because INR monitoring is not required.
Antiplatelet drugsDelayed hemostasis due to aspirin, clopidogrel, etc.
Valsalva maneuverVascular rupture due to increased venous pressure from coughing, vomiting, constipation, weightlifting, etc.
ConjunctivochalasisConjunctival vascular damage due to increased friction
Acute hemorrhagic conjunctivitisInflammatory vascular damage caused by enterovirus 70 and coxsackievirus A24

Idiopathic subconjunctival hemorrhage refers to cases where no clear trigger can be identified, with unexplained cases accounting for about half in some reports12). Age-related fragility of conjunctival blood vessels is thought to be involved. Subconjunctival hemorrhage can occur after situations involving sudden venous congestion, such as Valsalva maneuvers, pertussis, vomiting, sneezing, and weightlifting12).

Traumatic subconjunctival hemorrhage results from direct ocular contusion, foreign bodies, contact lens manipulation, or eye rubbing. In children, accidental contact during tag or ball games is a common cause. In traumatic cases, always check for hyphema, iris dialysis, lens subluxation, commotio retinae, and globe rupture. Particularly, 360-degree subconjunctival hemorrhage, marked hypotony, or vision loss strongly suggests occult globe rupture, warranting orbital CT and exploratory surgery.

Hypertension-related subconjunctival hemorrhage is the most common known cause in patients aged 50 and older. Mimura et al. reported a significantly higher prevalence of hypertension in recurrent cases10). With the widespread use of home blood pressure monitoring, untreated hypertension is increasingly discovered following subconjunctival hemorrhage.

Anticoagulant and antiplatelet-related subconjunctival hemorrhage has an incidence of 3.7% with warfarin (vs. 1.7% in non-users)7), and a similar risk is estimated with the recent widespread use of DOACs. As treatment for atrial fibrillation and venous thrombosis increases in elderly patients, this remains an important cause.

Traumatic asphyxia: Sudden compression of the chest and abdomen causes blood to flow backward from the right atrium through the valveless innominate vein and jugular vein, producing petechiae and subconjunctival hemorrhage in the head and neck. This is known as “masque ecchymotique.” It is very rare in children, but a case has been reported of bilateral subconjunctival hemorrhage and facial edema after a tractor rollover accident6).

Tumors: Kaposi sarcoma masquerading as subconjunctival hemorrhage has been reported. A 34-year-old man with undiagnosed HIV presented with 3 months of spontaneous left eye redness, and Kaposi sarcoma was found in the inferior temporal fornix1). Recurrent subconjunctival hemorrhage can be the initial symptom of tumors such as cavernous hemangioma and lymphoma.

Systemic lupus erythematosus (SLE): Cases have been reported in which SLE and antiphospholipid antibody syndrome were diagnosed following subconjunctival hemorrhage. The patient presented with hypertension (140/110 mmHg), abdominal vein distention, and malar rash, and was diagnosed with inferior vena cava thrombosis and Budd-Chiari syndrome3).

Ocular vicarious menstruation: A very rare cause of subconjunctival hemorrhage that recurs monthly with menstruation. The mechanism is thought to be congestion and secondary bleeding of blood vessels with extrauterine estrogen and progesterone receptors. Oral contraceptives (levonorgestrel/ethinyl estradiol) markedly improve recurrence5).

Hemophilia: Severe subconjunctival hemorrhage has been reported after intravitreal anti-VEGF injection in patients with severe hemophilia A (factor VIII < 1%). Hemostasis was achieved with intravenous factor VIII administration, and subsequent preventive factor VIII administration before injections resulted in no recurrence2).

Q What should I do if subconjunctival hemorrhage occurs while taking anticoagulants?
A

If subconjunctival hemorrhage occurs while taking warfarin, a blood test should be performed to check whether the INR (international normalized ratio) exceeds the therapeutic range. A meta-analysis of cataract surgery found that the warfarin continuation group had approximately three times more bleeding events than the non-use group, but most were self-limiting subconjunctival hemorrhages that did not affect postoperative vision7). Do not stop anticoagulant medication on your own; consult your primary care physician.

Clinical Diagnosis

History taking: Assess for trauma, anticoagulant use, Valsalva maneuvers (coughing, vomiting, constipation, weightlifting), and association with menstruation.

Slit-lamp examination: Evaluate the extent, depth, and color of the subconjunctival hemorrhage. Carefully observe for the presence of conjunctival lacerations. Conjunctival lacerations hidden beneath the hemorrhage can easily be missed.

360-degree subconjunctival hemorrhage: May be a sign of occult globe rupture. Consider orbital CT and ocular exploration because zone II and III injuries cannot be ruled out.

Systemic Examination

Blood pressure measurement: Essential for screening of hypertension.

Blood tests: Check INR, PT, APTT, and platelet count in recurrent cases and patients on anticoagulants.

Systemic evaluation: In frequently recurring cases, add screening for coagulation abnormalities, autoimmune diseases, and malignancies3).

In recurrent cases, bilateral cases, and cases that do not resolve for a prolonged period, add the following tests in a stepwise manner.

  • Complete blood count (CBC) and peripheral blood smear: Rule out thrombocytopenia and hematologic disorders
  • Coagulation tests: PT-INR, APTT, fibrinogen, D-dimer
  • Liver and kidney function: Assess coagulation factor production and drug metabolism
  • Autoimmune screening: Antinuclear antibody, antiphospholipid antibody (to rule out SLE and antiphospholipid syndrome)3)
  • HIV antibody: To rule out conjunctival Kaposi sarcoma1)
  • Imaging: Orbital CT and MRI (when trauma or tumor is suspected)
  • Internal medicine consultation: Screening for hypertension, diabetes, and liver cirrhosis

In frequently recurring cases or cases that do not resolve for a prolonged period, poor control of systemic disease or blood/vascular abnormalities should be considered, and further internal medicine evaluation should be added.

Differential DiagnosisKey Points for Differentiation
Bacterial / Allergic ConjunctivitisRedness, discharge, itching, bilateral
Acute Hemorrhagic ConjunctivitisBilateral, follicular conjunctivitis, preauricular lymphadenopathy, epidemic history
Kaposi SarcomaDark red nodule, HIV-related 1)
Globe RuptureTrauma history, 360-degree hemorrhage, hyphema
Conjunctival Malignant TumorMass that does not resolve over a long period, vascular proliferation

Subconjunctival hemorrhage is a self-limiting condition that resolves spontaneously within 1 to 4 weeks. If an underlying cause is identified, treatment should be directed at the primary condition. The subconjunctival hemorrhage itself is left to follow its natural course.

No eye drops with insurance coverage exist for subconjunctival hemorrhage itself. For discomfort caused by tear film disruption, supportive therapy with frequent instillation of artificial tears is performed. When ocular surface diseases such as dry eye, punctate keratopathy, or conjunctivochalasis are present, dry eye medications (diquafosol sodium 3% ophthalmic solution, rebamipide 2% suspension ophthalmic solution, sodium hyaluronate ophthalmic solution, etc.) are prescribed based on each specific diagnosis.

For recurrent subconjunctival hemorrhage, capillary strengthening agents such as carbazochrome sodium sulfonate (Adona® tablets 30 mg, 3 times daily) may be used. However, the level of evidence is not high, and its use is limited to empirical treatment of idiopathic recurrent cases.

In patients with hemophilia A, severe subconjunctival hemorrhage can occur after intravitreal injection. There are reports that prophylactic administration of factor VIII (intravenous administration 4 hours before injection) can prevent bleeding complications2). Close collaboration with a hematologist is important.

In patients taking warfarin who experience recurrent subconjunctival hemorrhage, a blood test should be performed to confirm that the INR (international normalized ratio) does not exceed the therapeutic range (typically 2.0–3.0). Discontinuing anticoagulants without medical advice is strictly prohibited as it carries a risk of cerebral infarction or cardioembolism; any dosage adjustment must be made in consultation with the prescribing physician. In patients taking DOACs, regular INR monitoring is unnecessary, but overdose detection tends to be delayed; therefore, strict dose adjustment according to renal function is essential.

There is no direct surgical indication for subconjunctival hemorrhage itself. When conjunctivochalasis is suspected and bleeding recurs repeatedly, conjunctivochalasis surgery (conjunctival resection) can reduce recurrence. The procedure involves crescent-shaped excision of the loose redundant conjunctiva in the inferior bulbar conjunctiva, followed by reattachment or spontaneous adhesion to Tenon’s capsule and the scleral surface. Cautery excision using a high-frequency radio-knife or thermoblade is also used.

Q Is there a way to make subconjunctival hemorrhage heal faster?
A

At present, there is no established treatment that promotes absorption of subconjunctival hemorrhage. It usually resolves spontaneously within 1 to 4 weeks. During the absorption process, the color changes to pink, orange, or yellow, which is a normal course. There are anecdotal reports that warm compresses may promote absorption, but the evidence is limited.

6. Pathophysiology and Detailed Mechanisms

Section titled “6. Pathophysiology and Detailed Mechanisms”

Damage to conjunctival blood vessels causes bleeding between Tenon’s capsule and the conjunctiva. In younger individuals, bleeding rarely spreads across the entire conjunctiva, but in older adults, the elastic and connective tissues between Tenon’s capsule and the conjunctiva are fragile, making extensive spread more likely.

Blunt trauma to the chest and abdomen generates positive pressure within the mediastinum. This positive pressure causes blood to flow backward from the right atrium into the valveless brachiocephalic veins and jugular veins, resulting in a sudden pressure increase in the venous bed of the head and neck. This leads to the development of petechiae 6). The absence of petechiae in the lower body is thought to be because the valves of the lower extremity veins control the pressure increase 6).

Drainage by Conjunctival Lymphatic Vessels

Section titled “Drainage by Conjunctival Lymphatic Vessels”

The involvement of conjunctival lymphatic vessels in the absorption of subconjunctival hemorrhage has been reported. In a case of SCH that occurred after subconjunctival anesthesia during cataract surgery, intraoperative OCT revealed a sac-like blood-filled structure adjacent to the bleeding site. It was identified as a lymphatic vessel because it had a valve-like structure 4). Marked resolution of the SCH was observed from postoperative day 1 to day 2, suggesting that lymphatic vessels may facilitate blood clearance from the subconjunctival space 4).

Conjunctival Microvascular Damage due to Diabetes

Section titled “Conjunctival Microvascular Damage due to Diabetes”

In type 2 diabetes, dilation, heterogeneous distribution, increased tortuosity, and changes in blood flow velocity have been reported in conjunctival microvessels 8). These microvascular abnormalities increase the fragility of conjunctival blood vessels and raise the risk of subconjunctival hemorrhage. It is reported that the longer the duration of diabetes and the higher the HbA1c level, the higher the frequency of recurrent subconjunctival hemorrhage.

Systemic hypertension is the main cause of subconjunctival hemorrhage in people over 50 years old. Chronic blood pressure elevation causes intimal thickening and medial degeneration of arterioles, leading to reduced elasticity of conjunctival vessels. Sudden blood pressure fluctuations (coughing, straining, weightlifting, acute stress) cause fragile blood vessels to rupture. It has been suggested that some cases classified as idiopathic may include undiagnosed borderline hypertension.

Pathological Mechanism of Acute Hemorrhagic Conjunctivitis

Section titled “Pathological Mechanism of Acute Hemorrhagic Conjunctivitis”

Enterovirus 70 and Coxsackievirus A24 variant (CA24v) are single-stranded positive-sense RNA viruses belonging to the Picornaviridae family and have no envelope9). Infection of conjunctival epithelial cells releases local inflammatory cytokines, increasing conjunctival capillary permeability and causing petechial and patchy hemorrhages. After the third day of illness, viral RNA detection by RT-PCR becomes difficult, so specimen collection for diagnosis should be performed early in the course of the disease9).

Q How is subconjunctival hemorrhage absorbed?
A

It was previously thought that blood in the subconjunctival space was naturally broken down and absorbed. Recent studies have suggested that conjunctival lymphatic vessels may be involved in blood drainage4). Blood has been observed inside lymphatic vessels with valve-like structures on intraoperative OCT, and it has been reported that lymphatic vessels contribute to macromolecular clearance from the subconjunctival space.

Discovery of Conjunctival Lymphatic Drainage

Section titled “Discovery of Conjunctival Lymphatic Drainage”

The drainage mechanism of subconjunctival hemorrhage via conjunctival lymphatics was first demonstrated using intraoperative OCT4). This finding may also be applied to predicting the prognosis of blebs in glaucoma filtration surgery. It has been hypothesized that healthy conjunctival lymphatics may help drain aqueous humor and inflammatory mediators, potentially improving filtration surgery outcomes4).

Anticoagulant and Antiplatelet Therapy in Ophthalmic Procedures

Section titled “Anticoagulant and Antiplatelet Therapy in Ophthalmic Procedures”

With the widespread use of direct oral anticoagulants (DOACs), evaluating the safety of ophthalmic surgery and intravitreal injections under continued anticoagulation, including warfarin, has become a challenge. According to the AAO Preferred Practice Pattern, based on meta-analysis results of cataract surgery, it is recommended in principle to perform surgery without discontinuing anticoagulants or antiplatelet agents7). Most hemorrhagic complications are limited to spontaneously resolving subconjunctival hemorrhages and rarely cause significant vision loss7).

Molecular Diagnostics and Epidemic Surveillance

Section titled “Molecular Diagnostics and Epidemic Surveillance”

In Japan, molecular epidemiological analysis using RT-PCR for acute hemorrhagic conjunctivitis has been established since 1996, enabling phylogenetic analysis of viral strains and tracking of epidemic patterns9,11). The 2025 edition of the Clinical Practice Guidelines for Viral Conjunctivitis states that although rapid diagnostic kits for EV70 and CA24v have not been developed, genotyping is possible through testing requests to research institutions9).

It has been suggested that the anti-adhesive effect and local fibrinolytic stimulation of anti-VEGF drugs may influence bleeding risk, but systemic anti-VEGF concentrations after intravitreal injection are extremely low, and the impact in clinical practice remains unclear2). Further accumulation of data on the safety of ophthalmic procedures in patients with coagulation disorders is needed.

1. What is traumatic subconjunctival hemorrhage?

Section titled “1. What is traumatic subconjunctival hemorrhage?”

Traumatic subconjunctival hemorrhage is a condition in which a conjunctival blood vessel ruptures due to a blow or other eye trauma, and blood collects in the subconjunctival space (between the bulbar conjunctiva and Tenon’s capsule). It is said to account for 10–20% of all subconjunctival hemorrhages12).

Unlike non-traumatic subconjunctival hemorrhage (idiopathic, hypertension, anticoagulant use, Valsalva maneuvers, etc.), traumatic cases are clinically important because they can be a sign of serious injury inside the eye. Subconjunctival hemorrhage itself is benign, but when it is seen after trauma, it is necessary to systematically rule out hidden ocular injury.

Subconjunctival hemorrhage is found in about 3% of ophthalmology outpatients and reaches 10.1% in people aged 65 years or older10). Idiopathic cases are estimated to account for 30–50% of all subconjunctival hemorrhages, hypertension for 10–30%, and trauma for 10–20%. Detailed epidemiologic data limited to traumatic cases are scarce, but sports, work, traffic accidents, and accidents at home are the main causes of injury.

If there is no associated intraocular injury, traumatic subconjunctival hemorrhage is absorbed naturally within 1 to 4 weeks and leaves no lasting effects. During the absorption process, the blood changes from red to purple to blue-green to yellow. It does not affect vision. However, the presence or absence of an associated ocular injury determines the prognosis, so careful initial evaluation is essential.

Q My white of the eye turned bright red after an injury. Is that okay?
A

The subconjunctival hemorrhage itself resolves naturally in 1 to 4 weeks and does not affect vision. However, subconjunctival hemorrhage after trauma can be a sign of injury inside the eye (globe rupture, conjunctival laceration, hyphema, etc.), so it is important to see an ophthalmologist even if there is no pain. In particular, 360-degree subconjunctival hemorrhage or cases with decreased vision or marked low intraocular pressure are urgent.

Typical case of traumatic subconjunctival hemorrhage: bright red, sharply demarcated hemorrhagic patch
Flather D. Subconjunctival hemorrhage eye. Wikimedia Commons. 2011. License: CC BY-SA 3.0. URL: https://commons.wikimedia.org/wiki/File:Subconjunctival_hemorrhage_eye.JPG
A bright red, sharply demarcated hemorrhagic patch is visible beneath the bulbar conjunctiva. It shows blood accumulating beneath the conjunctiva after trauma.
  • Usually asymptomatic: isolated subconjunctival hemorrhage does not cause pain or vision loss. Eye pain after trauma is due to associated injuries (corneal epithelial abrasion, hyphema, etc.).
  • Noticing the redness: often noticed in the mirror or after someone else points it out.
  • Foreign body sensation: some people may complain of dry-eye-like symptoms.

Clinical findings (findings the doctor confirms on examination)

Section titled “Clinical findings (findings the doctor confirms on examination)”
  • Hemorrhagic patch: a bright red or dark red patch is visible beneath the bulbar conjunctiva. It can range from a small, spot-like or stain-like localized area to a broad area spreading across the entire bulbar conjunctiva. As it is absorbed, it changes to pink, orange, and yellow.
  • Direction of spread of the hemorrhage: over time, it moves downward from the palpebral fissure and spreads.
  • Associated conjunctival laceration: a conjunctival laceration hidden by the hemorrhage is easy to miss. Fluorescein staining and careful slit-lamp examination are necessary.
  • Associated findings: systematically assess for hyphema, iridodialysis, lens subluxation, vitreous hemorrhage, and commotio retinae.

Features of a benign course

Localized hemorrhage: the bleeding remains limited to part of the conjunctiva.

Normal pupil: Normal light response and pupil shape.

Normal vision: Corrected vision is the same as before the injury.

Warning signs that suggest globe rupture

360-degree subconjunctival hemorrhage: Bleeding all around the eye is an important sign of a possible occult globe rupture.

Findings suggestive of globe wall injury: Deformation of the globe, displacement of the pupil, shallowness of the anterior chamber, etc.

Pupil deviation, distortion, or fixation: Suggests prolapse of anterior segment tissue.

Anterior chamber hemorrhage and decreased vision: Suggests severe injury inside the eye.

Q What should I do if the white of the eye is completely red?
A

360-degree subconjunctival hemorrhage may be a sign of a possible occult globe rupture. If it is accompanied by marked low eye pressure, decreased vision, or pupil distortion, the situation is urgent, and orbital CT and ocular exploration may be considered. If these findings are present, you need to see an eye specialist on the same day.

The mechanisms of injury in traumatic subconjunctival hemorrhage are varied.

  • Blunt trauma: direct or indirect force from a fist, ball, elbow, fall, or traffic accident
  • Sharp trauma: penetration or perforation caused by glass shards, metal fragments, tree branches, pencils, and similar objects
  • Iatrogenic: after cataract surgery, intravitreal injection, conjunctival anesthesia, device placement, and similar procedures
  • Children: playground accidents, ball sports, contact between children

The following risk factors increase the incidence of subconjunctival hemorrhage, whether traumatic or non-traumatic.

  • Anticoagulant use: the incidence of SCH in warfarin users is 3.7% (1.7% in non-users)7). DOACs are also thought to carry a similar risk.
  • Antiplatelet drugs: delayed hemostasis with aspirin, clopidogrel, and similar drugs.
  • Hypertension: reduced elasticity of conjunctival blood vessels due to chronic blood pressure elevation.
  • Diabetes: weakening of conjunctival blood vessels due to microvascular damage7).
  • Older age: bleeding spreads more easily because elastic tissue and connective tissue between Tenon’s capsule and the conjunctiva become weaker.

Initial management algorithm for traumatic subconjunctival hemorrhage

Section titled “Initial management algorithm for traumatic subconjunctival hemorrhage”

Evaluate subconjunctival hemorrhage after trauma systematically using the following steps.

  1. Visual acuity testing and pupillary light reflex check: Check for changes in vision before and after the injury and for abnormal pupils.
  2. Slit-lamp microscopy: Assess the extent and depth of the bleeding and whether there is a conjunctival laceration. A laceration hidden by the bleeding is easy to miss.
  3. Fluorescein staining and Seidel test: Check for conjunctival laceration and corneal epithelial damage, and detect an open globe wound (aqueous leakage).
  4. Intraocular pressure assessment: Assess whether measurement is feasible based on trauma findings. Low intraocular pressure is a clue to globe rupture.
  5. Dilated fundus examination: Rule out commotio retinae, retinal tears, and vitreous hemorrhage.
  6. When 360-degree hemorrhage plus low intraocular pressure is recognized: Consider orbital CT and exploration of the globe.

Clinical diagnosis

History taking: Check the circumstances of the injury, how it happened, and any history of taking anticoagulants.

Slit-lamp microscopy: assess the extent and color of the hemorrhage, and check for conjunctival laceration and corneal damage.

Seidel test: after fluorescein staining, confirm whether there is any aqueous humor leakage from the bleeding site.

Intraocular pressure measurement: Decide whether to perform it according to the trauma findings. Low intraocular pressure suggests globe rupture.

Systemic and imaging tests

Blood pressure measurement: essential as screening for hypertension.

Blood tests: in patients taking anticoagulants, check INR, PT, APTT, and platelet count.

Orbital CT: in cases of 360-degree hemorrhage or low intraocular pressure, evaluate the continuity of the globe wall, intraocular foreign bodies, and the presence of fractures.

Dilated fundus examination: to rule out commotio retinae, retinal tears, and vitreous hemorrhage.

It is necessary to distinguish this from the following conditions.

Differential diseasesDifferentiating points
Idiopathic subconjunctival hemorrhageNo history of trauma, normal intraocular pressure, benign course
Globe rupture360-degree hemorrhage, low intraocular pressure, pupil deformity, hyphema
Conjunctival lacerationLaceration beneath the hemorrhage, Seidel test positive
Acute hemorrhagic conjunctivitisBilateral, follicular conjunctivitis, preauricular lymph node swelling, epidemic history
Subconjunctival Kaposi sarcomaDark red nodules, HIV-related, does not resolve for a long time

Treatment of the underlying disease is the top priority

Section titled “Treatment of the underlying disease is the top priority”

The treatment of traumatic subconjunctival hemorrhage prioritizes treatment of the associated globe injury rather than the subconjunctival hemorrhage itself.

  • With conjunctival laceration: Small ones (<5 mm) can be observed; larger ones are sutured
  • With scleral laceration: Nylon suturing in the operating room
  • Globe rupture: Emergency wound closure surgery (primary repair)
  • With hyphema: Rest, steroid eye drops, and irrigation surgery if needed

Treatment of the subconjunctival hemorrhage itself

Section titled “Treatment of the subconjunctival hemorrhage itself”

If there is no associated globe injury, let the subconjunctival hemorrhage run its natural course. It is naturally absorbed in 1 to 4 weeks. There is currently no established treatment that speeds absorption.

MedicationDosageIndication
Artificial tearsInstill as neededSymptomatic relief of discomfort
Carbazochrome sodium sulfonate (Adona®) 30 mgTake orally 3 times a dayCapillary strengthening (if recurrent)

For bothersome symptoms, provide supportive care with artificial tears. If dry eye is present, consider prescribing 3% diquafosol sodium eye drops, 2% rebamipide suspension eye drops, sodium hyaluronate eye drops, and similar treatments. For repeated bleeding, carbazochrome sodium sulfonate (Adona® tablets 30 mg, taken orally 3 times a day) may be used, but the level of evidence is not high.

Management of patients taking anticoagulants

Section titled “Management of patients taking anticoagulants”

In patients taking warfarin, confirm by blood test whether the INR is within the therapeutic range (most often 2.0–3.0). Stopping anticoagulants on your own is strictly prohibited because it carries a risk of stroke and cardiogenic embolism. Be sure to discuss the matter with the primary doctor and respond accordingly 7).

Q Is there a way to make subconjunctival hemorrhage after trauma heal faster?
A

At present, there is no established treatment that promotes the absorption of subconjunctival hemorrhage. During the resorption process, it changes color from red to purple to blue-green to yellow, which is a normal course. Warm compresses are sometimes recommended empirically, but evidence is limited. If there is a concomitant eye injury (such as conjunctival laceration or hyphema), prioritize treatment of that injury.

Q I take blood thinners. If subconjunctival hemorrhage occurs, should I stop the medicine?
A

Stopping anticoagulants on your own is strictly prohibited because it carries a risk of stroke and cardiogenic embolism. Check that the therapeutic range is maintained with tests such as INR, and respond after consulting the primary doctor. The incidence of subconjunctival hemorrhage in patients taking warfarin is 3.7% (1.7% in non-users) 7), and after trauma the bleeding tends to spread more easily, but the decision to stop the medication should be made by a specialist.

6. Pathophysiology and detailed mechanisms of onset

Section titled “6. Pathophysiology and detailed mechanisms of onset”

Mechanism of vascular injury caused by trauma

Section titled “Mechanism of vascular injury caused by trauma”

Direct blunt force causes physical injury to the conjunctival vessels, allowing blood to leak into the subconjunctival space. In older adults, the elastic tissue and connective tissue between Tenon’s capsule and the conjunctiva are more fragile, so the same force is more likely to cause bleeding that spreads widely.

Subconjunctival hemorrhage associated with globe rupture

Section titled “Subconjunctival hemorrhage associated with globe rupture”

In globe rupture caused by blunt trauma, a sudden rise in intraocular pressure causes a tear at the thinnest part of the eyeball wall, near the corneal limbus and rectus muscle insertions. Intraocular blood and vitreous spill into the subconjunctival space, appearing as widespread subconjunctival hemorrhage. Circumferential subconjunctival hemorrhage is a characteristic finding of this mechanism.

Drainage through conjunctival lymphatic vessels

Section titled “Drainage through conjunctival lymphatic vessels”

It has been reported that conjunctival lymphatic vessels may be involved in the absorption of subconjunctival hemorrhage. Intraoperative OCT has shown blood within lymphatic vessels with valve-like structures adjacent to the bleeding site, suggesting that lymphatic vessels help clear blood from the subconjunctival space4).

Conjunctival microvascular damage due to diabetes

Section titled “Conjunctival microvascular damage due to diabetes”

In diabetes, the conjunctival microvessels may become dilated, tortuous, and show changes in blood flow speed, increasing vessel fragility. As a result, even minor trauma can more easily cause subconjunctival hemorrhage.

Demonstration of conjunctival lymphatic drainage

Section titled “Demonstration of conjunctival lymphatic drainage”

The drainage mechanism of subconjunctival hemorrhage through conjunctival lymphatic vessels was demonstrated for the first time using intraoperative OCT4). In a case of SCH that occurred during cataract surgery, blood transfer into lymphatic vessels with valve-like structures was confirmed, and marked resolution of SCH within 1 to 2 days after surgery was reported. This finding may also be useful for predicting outcomes after glaucoma filtering surgery.

Standardizing the initial care protocol for traumatic subconjunctival hemorrhage

Section titled “Standardizing the initial care protocol for traumatic subconjunctival hemorrhage”

Standardization of an algorithm to distinguish traumatic subconjunctival hemorrhage from globe rupture is needed. There are also reports that quantitative assessment of the depth and extent of subconjunctival hemorrhage using anterior segment OCT may help improve diagnostic accuracy, but it has not yet become widely used in clinical practice.

  1. Redzuwan NS, Ahmad Tarmizi NA, Mohd Khialdin S. From Simple to Sinister: Kaposi Sarcoma Masquerading as a Subconjunctival Hemorrhage. Cureus. 2023;15(9):e45296. doi:10.7759/cureus.45296. PMID:37846262; PMCID:PMC10576943.
  2. Kesav N, Mehra AA, Schmaier AH, Sobol W. Severe Subconjunctival Hemorrhage After Intravitreal Injection in a Patient With Hemophilia A. J VitreoRetinal Dis. 2023;7(4):333-336. doi:10.1177/24741264231159218.
  3. Sharma M, Viswanath S, Singh R. Eyes are a window to the body: A journey from subconjunctival hemorrhage to SLE and inferior vena cava stenting. Indian J Ophthalmol. 2024;72:1390. doi:10.4103/ijo.ijo_486_24.
  4. Lau AZ, Tang GY, Morgan WH, Chan GZ. Drainage of subconjunctival hemorrhage through conjunctival lymphatic pathways. American journal of ophthalmology case reports. 2025;39:102368. doi:10.1016/j.ajoc.2025.102368. PMID:40686767; PMCID:PMC12272577.
  5. Celebi ARC, Aygun EG. A rare cause of recurrent subconjunctival hemorrhage: ocular vicarious menstruation. GMS ophthalmology cases. 2023;13:Doc05. doi:10.3205/oc000213. PMID:36875630; PMCID:PMC9979076.
  6. Çik N, Başerdem O, Duman M, Yilmaz D. Traumatic asphyxia with a “masque ecchymotique” in a 14-year-old adolescent. Ulus Travma Acil Cerrahi Derg. 2023;29(4):543-545. doi:10.14744/tjtes.2022.53099. PMID:36995196; PMCID:PMC10214897.
  7. Miller KM, Oetting TA, Tweeten JP, Carter K, Lee BS, Lin S, et al. Cataract in the Adult Eye Preferred Practice Pattern. Ophthalmology. 2022;129(1):P1-P126. doi:10.1016/j.ophtha.2021.10.006. PMID:34780842.
  8. Bron AJ, de Paiva CS, Chauhan SK, Bonini S, Gabison EE, Jain S, et al. TFOS DEWS II pathophysiology report. The ocular surface. 2017;15(3):438-510. doi:10.1016/j.jtos.2017.05.011. PMID:28736340.
  9. 日本眼科学会・日本眼科医会・日本眼感染症学会・日本角膜学会. ウイルス性結膜炎診療ガイドライン(2025年版). 日眼会誌. 2025;129(12):1145-1200.
  10. Mimura T, Usui T, Yamagami S, Funatsu H, Noma H, Honda N, et al. Recent causes of subconjunctival hemorrhage. Ophthalmologica. Journal international d’ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde. 2010;224(3):133-7. doi:10.1159/000236038. PMID:19738393.
  11. Uchio E, Yamazaki K, Aoki K, Ohno S. Detection of enterovirus 70 by polymerase chain reaction in acute hemorrhagic conjunctivitis. American journal of ophthalmology. 1996;122(2):273-5. doi:10.1016/s0002-9394(14)72026-4. PMID:8694103.
  12. Tarlan B, Kiratli H. Subconjunctival hemorrhage: risk factors and potential indicators. Clinical ophthalmology (Auckland, N.Z.). 2013;7:1163-70. doi:10.2147/OPTH.S35062. PMID:23843690; PMCID:PMC3702240.

Copy the article text and paste it into your preferred AI assistant.